Before Guillain‐Barre Syndrome Is Attributed to a CMV Infection, the Diagnosis Must Be Confirmed and Other Causes Must Be Ruled Out
The Kaohsiung Journal of Medical Sciences · 08.07.2026
DOI: 10.1002/kjm2.70264 ↗Kurz gefasst
Leserbrief in der Zeitschrift The Kaohsiung Journal of Medical Sciences, online erschienen am 08.07.2026. Verfasst von Josef Finsterer. Beteiligte Einrichtung: Department of Neurology, Neurology and Neurophysiology Center, Vienna, Austria. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
We read with interest the article by Hsu et al. [1] about a 47- year-old man with myeloid leukemia who was treated with idarubicin, cytarabine, decitabrine
Autor:innen und Institutionen
- Department of Neurology, Neurology and Neurophysiology Center, Vienna, Austria.
ORCID-Profile: Josef Finsterer
Zitieren
APA
Finsterer, J. (2026). Before Guillain‐Barre Syndrome Is Attributed to a CMV Infection, the Diagnosis Must Be Confirmed and Other Causes Must Be Ruled Out. The Kaohsiung Journal of Medical Sciences. https://doi.org/10.1002/kjm2.70264
Vancouver
Finsterer J. Before Guillain‐Barre Syndrome Is Attributed to a CMV Infection, the Diagnosis Must Be Confirmed and Other Causes Must Be Ruled Out. The Kaohsiung Journal of Medical Sciences. 2026. doi:10.1002/kjm2.70264
BibTeX
@article{Finsterer2026,
author = {Finsterer, Josef},
title = {Before Guillain‐Barre Syndrome Is Attributed to a CMV Infection, the Diagnosis Must Be Confirmed and Other Causes Must Be Ruled Out},
journal = {The Kaohsiung Journal of Medical Sciences},
year = {2026},
doi = {10.1002/kjm2.70264}
}
EUVIMED